Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

Alzheimer's and Dementia

Volumn 11, Issue 5, 2015, Pages 549-560

  O'Bryant, Sid E ^a   Gupta, Veer ^b   Henriksen, Kim ^c   Edwards, Melissa ^a   Jeromin, Andreas ^d   Lista, Simone ^e   Bazenet, Chantal ^f   Soares, Holly ^g   Lovestone, Simon ^f   Hampel, Harald ^e,h,i   Montine, Thomas ^j   Blennow, Kaj ^k   Foroud, Tatiana ^l   Carrillo, Maria ^m   Graff Radford, Neill ⁿ   Laske, Christoph ^o   Breteler, Monique ^p,q   Shaw, Leslie ^p,q   Trojanowski, John Q ^p,q   Schupf, Nicole ^r   Rissman, Robert A ^s   Fagan, Anne M ^t   Oberoi, Pankaj ^u   Umek, Robert ^v   Weiner, Michael W ^w   Grammas, Paula ^x   Posner, Holly ^y   Martins, Ralph ^b   more..

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b EDITH COWAN UNIVERSITY   (Australia)

^c NORDIC BIOSCIENCE A S   (Denmark)

^d Quanterix Inc   (United States)

^e AXA   (France)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g BRISTOL MYERS SQUIBB   (United States)

^h SORBONNE UNIVERSITÉ   (France)

ⁱ PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^j UNIVERSITY OF WASHINGTON   (United States)

^k SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^l INDIANA UNIVERSITY   (United States)

^m ALZHEIMER'S ASSOCIATION   (United States)

ⁿ MAYO CLINIC   (United States)

^o UNIVERSITY OF TÜBINGEN   (Germany)

^p UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^q GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^r UNIVERSITY OF PENNSYLVANIA   (United States)

^s Columbia University ^*  (United States)

^t UNIVERSITY OF CALIFORNIA   (United States)

^u WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^v Meso Scale Discovery   (United States)

^w UNIVERSITY OF CALIFORNIA   (United States)

^x TEXAS TECH UNIVERSITY   (United States)

^y PFIZER INC   (United States)

more..

Author keywords

Alzheimer's disease; Biomarkers; Blood; Dementia; Diagnosis; Plasma; Serum; Treatment

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; ARTICLE; BLOOD; BLOOD SAMPLING; CEREBROSPINAL FLUID; DEMENTIA; GERIATRIC PATIENT; HUMAN; LABORATORY TEST; NEUROIMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARDIZATION; STANDARDS;

ALZHEIMER DISEASE; BIOMARKERS; GUIDELINES AS TOPIC; HUMANS;

EID: 84929264851     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2014.08.099     Document Type: Review

References (102)

1. J.P. Ioannidis Why most published research findings are false PLoS Med 2 2005 e124
2. F.S. Collins, and L. Tabak NIH plans to enhance reproducibility Nature 505 2014 612 613
3. Trouble at the lab 2013 The Economist Available at http://www.economist.com/news/briefing/21588057-scientists-think-science-self-correcting-alarming-degree-it-not-trouble Accessed February 27, 2014
4. F. Prinz, T. Schlange, and K. Asadullah Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10 2011 712 713
5. K. Henriksen, S. O'Bryant, H. Hampel, J.Q. Trojanowski, T.J. Montine, and A. Jeromin The future of blood-based biomarkers for Alzheimer's disease Alzheimers Dement 10 2014 115 131
6. L.J. Thal, K. Kantarci, E.M. Reiman, W.E. Klunk, M.W. Weiner, and H. Zetterberg The role of biomarkers in clinical trials for Alzheimer disease Alzheimer Dis Assoc Disord 20 2006 6 15
7. P. Schneider, H. Hampel, and K. Buerger Biological marker candidates of Alzheimer's disease in blood, plasma, and serum CNS Neurosci Ther 15 2009 358 374
8. W. Thies, and L. Bleiler Alzheimer's Association. 2013 Alzheimer's disease facts and figures Alzheimers Dement 9 2013 208 245
9. M.D. Hurd, P. Martorell, A. Delavande, K.J. Mullen, and K.M. Langa Monetary costs of dementia in the United States N Engl J Med 368 2013 1326 1334
10. Alzheimer's Association. Changing the trajectory of Alzheimer's disease 2010. Available at: http://www.alz.org/documents-custom/trajectory.pdf. Accessed September 15, 2014.
11. Anonymous Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group Neurobiol Aging 19 1998 109 116 [see comment][erratum appears in Neurobiol Aging 1998 May-Jun;19(3):285]
12. K. Blennow Biomarkers in Alzheimer's disease drug development Nat Med 16 2010 1218 1222
13. R.C. Petersen, and J.Q. Trojanowski Use of Alzheimer disease biomarkers: potentially yes for clinical trials but not yet for clinical practice JAMA 302 2009 436 437
14. H. Hampel, and S. Lista Use of biomarkers and imaging to assess pathophysiology, mechanisms of action and target engagement J Nutr Health Aging 17 2013 54 63
15. K. Blennow, H. Hampel, and H. Zetterberg Biomarkers in amyloid-β immunotherapy trials in Alzheimer's disease Neuropsychopharmacology 39 2014 189 201
16. K. Blennow, H. Hampel, M. Weiner, and H. Zetterberg Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat Rev Neurol 6 2010 131 144
17. N. Mattsson, U. Andreasson, S. Persson, H. Arai, S.D. Batish, and S. Bernardini The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers Alzheimers Dement 7 2011 386 395.e6
18. S. Ray, M. Britschgi, C. Herbert, Y. Takeda-Uchimura, A. Boxer, and K. Blennow Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins Nat Med 13 2007 1359 1362
19. H.D. Soares, Y. Chen, M. Sabbagh, A. Rohrer, E. Schrijvers, and M. Breteler Identifying early markers of Alzheimer's disease using quantitative multiplex proteomic immunoassay panels Ann NY Acad Sci 1180 2009 56 67
20. Eli Lilly and Company. FDA Approves Amyvid™ (Florbetapir F 18 Injection) for Use in Patients Being Evaluated for Alzheimer's Disease and Other Causes of Cognitive Decline. Available at: https://investor.lilly.com/releasedetail2.cfm?ReleaseID=662647. Accessed September 15, 2014.
21. B.B. Booij, T. Lindahl, P. Wetterberg, N.V. Skaane, S. Saebo, and G. Feten A gene expression pattern in blood for the early detection of Alzheimer's disease J Alzheimers Dis 23 2011 109 119
22. K. Buerger, A. Ernst, M. Ewers, O. Uspenskaya, M. Omerovic, and N.G. Morgenthaler Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio Biol Psychiatry 65 2009 979 984
23. C. Laske, T. Leyhe, E. Stransky, N. Hoffmann, A.J. Fallgatter, and J. Dietzsch Identification of a blood-based biomarker panel for classification of Alzheimer's disease Int J Neuropsychopharmacol 14 2011 1147 1155
24. C. Laske, M. Schmohl, T. Leyhe, E. Stransky, W. Maetzler, and D. Berg Immune profiling in blood identifies sTNF-R1 performing comparably well as biomarker panels for classification of Alzheimer's disease patients J Alzheimers Dis 34 2013 367 375
25. S.E. O'Bryant, G. Xiao, R. Barber, J. Reisch, R. Doody, and T. Fairchild A serum protein-based algorithm for the detection of Alzheimer disease Arch Neurol 67 2010 1077 1081
26. S.E. O'Bryant, G. Xiao, R. Barber, R. Huebinger, K. Wilhelmsen, and M. Edwards A blood-based screening tool for Alzheimer's disease that spans serum and plasma: findings from TARC and ADNI PLoS One 6 2011 e28092
27. E. Nagele, M. Han, C. DeMarshall, B. Belinka, and R. Nagele Diagnosis of Alzheimer's disease based on disease-specific autoantibody profiles in human sera PLoS One 6 2011 e23112
28. M.M. Reddy, R. Wilson, J. Wilson, S. Connell, A. Gocke, and L. Hynan Identification of candidate IgG biomarkers for Alzheimer's disease via combinatorial library screening Cell 144 2011 132 142
29. J.D. Doecke, S.M. Laws, N.G. Faux, W. Wilson, S.C. Burnham, and C.P. Lam Blood-based protein biomarkers for diagnosis of Alzheimer disease Arch Neurol 69 2012 1318 1325
30. W.T. Hu, D.M. Holtzman, A.M. Fagan, L.M. Shaw, R. Perrin, and S.E. Arnold Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease Neurology 79 2012 897 905
31. S.E. O'Bryant, G. Xiao, R. Barber, J. Reisch, J. Hall, and C.M. Cullum A blood-based algorithm for the detection of Alzheimer's disease Dement Geriatr Cogn Disord 32 2011 55 62
32. A.M. Fagan, C.M. Roe, C. Xiong, M.A. Mintun, J.C. Morris, and D.M. Holtzman Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults Arch Neurol 64 2007 343 349
33. O. Hansson, H. Zetterberg, P. Buchhave, E. Londos, K. Blennow, and L. Minthon Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study Lancet Neurol 5 2006 228 234
34. S.J. Kiddle, M. Sattlecker, P. Proitsi, A. Simmons, E. Westman, and C. Bazenet Candidate blood proteome markers of Alzheimer's disease onset and progression: a systematic review and replication study J Alzheimer Dis 38 2014 515 531
35. S. Lista, F. Faltraco, D. Prvulovic, and H. Hampel Blood and plasma-based proteomic biomarker research in Alzheimer's disease Prog Neurobiol 101-102 2013 1 17
36. S. Lista, F. Faltraco, and H. Hampel Biological and methodological challenges of blood-based proteomics in the field of neurological research Prog Neurobiol 101-102 2013 18 34
37. A.J. Rai, and F. Vitzthum Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: Implications for clinical proteomics Expert Rev Proteomics 3 2006 409 426
38. N. Tatsumi, S. Miwa, S.M. Lewis for the International Society of Hematology and the International Council for Standardization in Haematology Specimen collection, storage, and transmission to the laboratory for hematological tests Int J Hematol 75 2002 261 268
39. S. Narayanan Effect of anticoagulants used for blood collection on laboratory tests Proc JCLA 7 1993 1 10
40. M. Weber, B. Rabenau, M. Stanisch, H.M. Nef, H. Mollmann, and A. Elsasser Influence of sample type on soluble CD40 ligand assessment in patients with acute coronary syndromes Thromb Res 120 2007 811 814
41. H.J. Issaq, Z. Xiao, and T.D. Veenstra Serum and plasma proteomics Chemical Reviews 107 2007 3601 3620
42. D. Galasko, and T.E. Golde Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems Alzheimers Res Ther 5 2013 10
43. A. Rembach, T.M. Ryan, B.R. Roberts, J.D. Boecke, W.J. Wilson, and A.D. Watt Progress towards a consensus on biomarkers for Alzheimer's disease: a review of peripheral analytes Biomark Med 7 2013 641 662
44. A.D. Watt, K.A. Perez, A.R. Rembach, C.L. Masters, V.L. Villemagne, and K.J. Barnham Variability in blood-based amyloid-β assays: the need for consensus on pre-analytical processing J Alzheimers Dis 30 2012 323 336
45. H. Vanderstichele, E. Van Kerschaver, C. Hesse, P. Davidsson, M.A. Buyse, and N. Andreasen Standardization of measurement of β-amyloid (1-42) in cerebrospinal fluid and plasma Amyloid 7 2000 245 258
46. M.C. Carrillo, K. Blennow, H. Soares, P. Lewczuk, N. Mattsson, and P. Oberoi Global standardization measurement of cerebral spinal fluid for Alzheimer's disease: an update from the Alzheimer's Association Global Biomarkers Consortium Alzheimers Dement 9 2013 137 140
47. N. Mattsson, U. Andreasson, S. Persson, M.C. Carrillo, S. Collins, and S. Chalbot CSF biomarker variability in the Alzheimer's Association quality control program Alzheimers Dement 9 2013 251 261
48. National Cancer Institute. NCI best practices for biospecimen resources 2007. Available at: http://biospecimens.cancer.gov/bestpractices/2011-NCIBestPractices.pdf. Accessed September 15, 2014.
49. P. De Paoli Biobanking in microbiology: from sample collection to epidemiology, diagnosis and research FEMS Microbiol Rev 29 2005 897 910
50. A.J. Rai, C.A. Gelfand, B.C. Haywood, D.J. Warunek, J. Yi, and M.D. Schuchard HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples Proteomics 5 2005 3262 3277
51. F.S. Apple, R.L. Jesse, L.K. Newby, A.H. Wu, and R.H. Christenson National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes Circulation 115 2007 e352 e355
52. G. Lippi, K. Becan-McBride, D. Behúlová, R.A. Bowen, S. Church, and J. Delanghe Preanalytical quality improvement: in quality we trust Clin Chem Lab Med 51 2013 229 241
53. F. Ceriotti, P. Cappelletti, M. Caputo, F. Di Serio, G. Messeri, and C. Ottomano A risk-analysis approach to the evaluation of analytical quality Clin Chem Lab Med 50 2011 67 71
54. H.M. Snyder, M.C. Carrillo, F. Grodstein, K. Henriksen, A. Jeromin, and S. Lovestone Developing novel blood-based biomarkers for Alzheimer's disease Alzheimers Dement 10 2010 109 114
55. The Alzheimer Research Center. Available at: http://arcresearch.eu/. Accessed February 27, 2014.
56. Alzheimer's Disease Cooperative Study. Available at: http://www.adcs.org/. Accessed February 27, 2014.
57. Alzheimer's Disease Neuroimaging Initiative. Available at: http://www.adni-info.org/. Accessed February 27, 2014.
58. K.A. Ellis, A.I. Bush, D. Darby, D. De Fazio, J. Foster, and P. Hudson The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for longitudinal study of Alzheimer's disease Int Psychogeriatr 21 2009 672 687
59. The Australian Imaging, Biomarker & Lifestyle Flagship Study of Ageing. Available at: http://www.aibl.csiro.au/. Accessed Feburary 27, 2014.
60. J.C. Morris, P.S. Aisen, R.J. Bateman, T.L. Benzinger, N.J. Cairns, and A.M. Fagan Developing an international network for Alzheimer's research: the Dominantly Inherited Alzheimer Network Clinical Investigation 2 2012 975 984
61. The Dominantly Inherited Alzheimer Network. Available at: http://www.dian-info.org/. Accessed Feburary 27, 2014.
62. R.J. Bateman, P.S. Aisen, B. De Strooper, N.C. Fox, C.A. Lemere, and J.M. Ringman Autosomal-dominant Alzheimer's disease: a review and proposal for the prevention of Alzheimer's disease Alzheimers Res Ther 3 2011 1
63. Institute for Aging & Alzheimer's Disease Research. Available at: http://web.unthsc.edu/research/IAADR. Accessed on Feburary 28, 2014.
64. King's College Londong. Available at: http://www.kcl.ac.uk/. Accessed Feburary 28, 2014.
65. L. Honig, W. Kukull, and R. Mayeux Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center Neurology 64 2005 494 500
66. Texas Alzheimer's Research and Care Consortium. Available at: http://www.txalzresearch.org/. Accessed Feburary 27, 2014.
67. M. Coats, and J.C. Morris Antecedent biomarkers of Alzheimer's disease: the adult children study J Geriatr Psychiatry Neurol 18 2005 242 244
68. Charles F. and Joanne Knight Alzheimer's Disease Research Center. Available at: http://alzheimer.wustl.edu/. Accessed Feburary 27, 2014.
69. P. Bonini, M. Plebani, F. Ceriotti, and F. Rubboli Errors in laboratory medicine Clin Chem 48 2002 691 698
70. D.J. Boone, S.D. Steindel, R. Herron, P.J. Howanitz, P. Bachner, and F. Meier Transfusion medicine monitoring practices: a study of the College of American Pathologists/Centers for Disease Control and Prevention Outcomes Working Group Arch Pathol Lab Med 119 1995 999 1006
71. M. Plebani, and P. Carraro Mistakes in a stat laboratory: types and frequency Clin Chem 43 1997 1348 1351
72. E. Schleicher The clinical chemistry laboratory: current status, problems and diagnostic prospects Anal Bioanal Chem 384 2006 124 131
73. R.E. Ferguson, D.F. Hochstrasser, and R.E. Banks Impact of preanalytical variables on the analysis of biological fluids in proteomic studies Proteomics Clin Appl 1 2007 739 746
74. K. Becan-McBride Laboratory sampling: does the process affect the outcome? J Intraven Nurs 22 1999 137 142
75. A. Dominguez-Rodriguez, and P. Abreu-Gonzalez Preanalytic conditions of the C-reactive protein are of paramount importance to use as a predictor of cardiovascular disease in clinical practice Int J Cardiol 158 2012 467
76. P. Wipfler, A. Heikkinen, A. Harrer, G. Pilz, A. Kunz, and S.M. Golaszewski Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis J Neurol 260 2013 221 227
77. D.R. Lachno, H. Vanderstichele, G. de Groote, V. Kostanjevecki, G. De Meyer, and E.R. Siemers The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma β-amyloid isoforms using the INNO-BIA plasma AB forms multiplex assay J Nutr Health Aging 13 2009 220 225
78. A. Domínguez Rodríguez, and P. Abreu González Diurnal variations in biomarkers used in cardiovascular medicine: clinical significance Rev Esp Cardiol 62 2009 1340 1341 author reply 1342-1343
79. CLSI. Procedures for handling and processing of blood specimens for common laboratory tests; Approved Guideline, 4th ed. Wayne, PA: Clinical and Laboratory Standards Institute; 2010:30;H18-A4.
80. C. Kennedy, S. Angermuller, R. King, S. Noviello, J. Walker, and J. Warden A comparison of hemolysis rates using intravenous catheters versus venipuncture tubes for obtaining blood samples J Emerg Nurs 22 1996 566 569
81. M.K. Sharp, and S.F. Mohammad Scaling of hemolysis in needles and catheters Ann Biomed Eng 26 1998 788 797
82. R.A. Bowen, G.L. Hortin, G. Csako, O.H. Otañez, and A.T. Remaley Impact of blood collection devices on clinical chemistry assays Clin Biochem 43 2010 4 25
83. L. Dugan, L. Leech, K.G. Speroni, and J.B. Corriher Factors affecting hemolysis rates in blood samples drawn from newly placed IV sites in the emergency department J Emerg Nurs 31 2005 338 345
84. A.K. Stankovic, and S. Smith Elevated serum potassium values: the role of preanalytic variables Am J Clin Pathol 121 2004 S105 112
85. S.L.F. Narayanan Sampling technique W. Shy, Therapeutic drug monitoring and toxicology by liquid chromatography 1985 Marcel Dekker, Inc New York, NY 79 88
86. G. Lippi, N. Blanckaert, P. Bonini, S. Green, S. Kitchen, and V. Palicka Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories Clin Chem Laboratory Med 46 2008 764 772
87. H. Tammen Specimen collection and handling: standardization of blood sample collection Methods Mol Biol 428 2008 35 42
88. C.A. Burtis, and E. Ashwood Tietz fundamentals of clinical chemistry 2001 W.B. Saunders Philadelphia, PA, USA
89. D.J. Ernst Plastic collection tubes decrease risk of employee injury MLO Med Lab Obs 33 2001 44 46 48, 50
90. A. Perret-Liaudet, M. Pelpel, Y. Tholance, B. Dumont, H. Vanderstichele, and W. Zorzi Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes J Alzheimers Dis 31 2012 13 20
91. P. Lewczuk, G. Beck, H. Esselmann, R. Bruckmoser, R. Zimmermann, and M. Fiszer Effect of sample collection tubes on cerebrospinal fluid concentrations of tau proteins and amyloid β peptides Clin Chem 52 2006 332 334
92. A. Perret-Liaudet, M. Pelpel, Y. Tholance, B. Dumont, H. Vanderstichele, and W. Zorzi Cerebrospinal fluid collection tubes: a critical issue for Alzheimers disease diagnosis Clin Chem 58 2012 787 789
93. A.M. Pica-Mendez, M. Tanen, A. Dallob, W. Tanaka, and O.F. Laterza Nonspecific binding of Aβ42 to polypropylene tubes and the effect of Tween-20 Clin Chim Acta 411 2010 1833
94. N.N. Rehak, and B.T. Chiang Storage of whole blood: effect of temperature on the measured concentration of analytes in serum Clin Chem 34 1988 2111 2114
95. B.L. Boyanton Jr., and K.E. Blick Stability studies of twenty-four analytes in human plasma and serum Clin Chem 48 2002 2242 2247
96. H. Mischak, R. Apweiler, R.E. Banks, M. Conaway, J. Coon, and A. Dominiczak Clinical proteomics: a need to define the field and to begin to set adequate standards Proteomics Clin Appl 1 2007 148 156
97. B.M. Murphy, S. Swarts, B.M. Mueller, P. van der Geer, M.C. Manning, and M.I. Fitchmun Protein instability following transport on dry ice Nat Methods 10 2013 278 298
98. WHO guidelines on drawing blood: best practices in phlebotomy. Available at: http://www.guideline.gov/content.aspx?id=37621. Accessed June 20, 2014.
99. S.E. O'Bryant Using blood markers for Alzheimer disease in clinical practice? Neurology 79 2012 846 847
100. R. Mayeux Evaluation and use of diagnostic tests in Alzheimer's disease Neurobiol Aging 19 1998 139 143
101. M.M. Breteler Mapping out biomarkers for Alzheimer disease JAMA 305 2011 304 305
102. Institute of Medicine. Evolution of translational omics: lessons learned and the path forward report brief 2012. Available at: http://www.iom.edu/Reports/2012/Evolution-of-Translational-Omics.aspx. Accessed on Feburary 28, 2014.